VC-backed Neurovance taps Goff as COO
Cambridge, Massachusetts-based Neurovance, a clinical-stage neuroscience-focused company, has named Brian Goff as chief operating officer and to its board of directors. Previously, Goff was president of Baxalta's hematology division. Neurovance's backers include Novartis Venture Fund, Venture Investors, Tekla Capital Management, GBS Venture Partners and State of Wisconsin Investment Board.
14 December 2016•3 mins read
